TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request November 14, 1986